EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Relationship between residual gastric content and peri‐operative semaglutide use assessed by gastric ultrasound: a prospective observational study

Rafael S F Nersessian, Leopoldo M da Silva, Marco Aurélio S Carvalho, Saullo Q Silveira, Arthur C V Abib, Fernando N Bellicieri, Helidea O Lima, Anthony M-H Ho, Gabriel S Anjos, Glenio B Mizubuti iD

Anaesthesia · 2024-12 · 79 (12) · 1317-1324

DOI: 10.1111/anae.16454 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Anaesthesia, online erschienen am 22.10.2024. Verfasst von Rafael S F Nersessian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesia, São Luiz Hospital (ITAIM/Rede D'Or), São Paulo, SP, Brazil. Hauptthemen laut MEDLINE: Glucagon-Like Peptides, Gastrointestinal Contents, Ultrasonography, Stomach. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Semaglutide is a long‐acting glucagon‐like peptide‐1 receptor agonist known to delay gastric emptying. Despite a growing body of evidence, its peri‐operative safety profile remains uncertain, particularly with regard to the risk of increased residual gastric content and aspiration of gastric contents during anaesthesia. We hypothesised that semaglutide interruption of ≤ 10 days before elective surgical procedures is insufficient to reduce or normalise the residual gastric content, despite fasting intervals that comply with current guidelines.

Methods

In this prospective observational study, we recruited patients who received pre‐operative once‐weekly subcutaneous semaglutide within 10 days of the procedure (semaglutide group) and control patients who had not been exposed to semaglutide (non‐semaglutide group). On the day of surgery, all patients underwent pre‐operative point‐of‐care gastric ultrasound to evaluate their residual gastric content. Increased residual gastric content was defined as any solid content or > 1.5 ml.kg ‐1 of clear fluids as assessed by gastric ultrasound.

Results

We recruited 220 patients, 107 in the semaglutide group and 113 in the non‐semaglutide group. Increased residual gastric content was found in 43/107 patients (40%) in the semaglutide group and 3/113 (3%) in the non‐semaglutide group (p < 0.001). In propensity‐weighted analysis, semaglutide use (OR 36.97, 95%CI 16.54–99.32), age (OR 0.95, 95%CI 0.93–0.98) and male sex (OR 2.28, 95%CI 1.29–4.06) were significantly associated with increased residual gastric content. There were no cases of pulmonary aspiration of gastric contents.

Conclusion

Pre‐operative semaglutide use within 10 days of elective surgical procedures was independently associated with increased risk of residual gastric content on pre‐operative gastric ultrasound assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like PeptidesGastrointestinal ContentsUltrasonographyStomachHumansFemaleMaleProspective StudiesMiddle AgedAgedGastric EmptyingAdultPerioperative CareHypoglycemic AgentsSemaglutide

Stichwörter der Autor:innen

aspiration of gastric contentsgastric ultrasoundpoint‐of‐care ultrasoundpre‐operative interruption intervalsemaglutide

Substanzen

Glucagon-Like PeptidesHypoglycemic AgentsSemaglutide

Autor:innen und Institutionen

  • Department of Anaesthesia, São Luiz Hospital (ITAIM/Rede D'Or), São Paulo, SP, Brazil.
  • Rede D'Or, D'Or Institute for Research and Education, São Paulo, SP, Brazil.
  • Department of Anaesthesia, São Luiz Hospital (Jabaquara/Rede D'Or-CMA), São Paulo, SP, Brazil.
  • Department of Anesthesiology and Perioperative Medicine, Queen's University, Kingston, ON, Canada.

ORCID-Profile: Glenio B Mizubuti

Zitieren

APA

Nersessian, R. S. F., da Silva, L. M., Carvalho, M. A. S., Silveira, S. Q., Abib, A. C. V., Bellicieri, F. N., Lima, H. O., Ho, A. M., Anjos, G. S., & Mizubuti, G. B. (2024). Relationship between residual gastric content and peri‐operative semaglutide use assessed by gastric ultrasound: a prospective observational study. Anaesthesia, 79(12), 1317-1324. https://doi.org/10.1111/anae.16454

Vancouver

Nersessian RSF, da Silva LM, Carvalho MAS, Silveira SQ, Abib ACV, Bellicieri FN, et al. Relationship between residual gastric content and peri‐operative semaglutide use assessed by gastric ultrasound: a prospective observational study. Anaesthesia. 2024;79(12):1317-1324. doi:10.1111/anae.16454

BibTeX
@article{Nersessian2024,
  author = {Nersessian, Rafael S F and da Silva, Leopoldo M and Carvalho, Marco Aurélio S and Silveira, Saullo Q and Abib, Arthur C V and Bellicieri, Fernando N and Lima, Helidea O and Ho, Anthony M-H and Anjos, Gabriel S and Mizubuti, Glenio B},
  title = {Relationship between residual gastric content and peri‐operative semaglutide use assessed by gastric ultrasound: a prospective observational study},
  journal = {Anaesthesia},
  year = {2024},
  volume = {79},
  number = {12},
  pages = {1317--1324},
  doi = {10.1111/anae.16454}
}
Kostenlos starten →